Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs QAAGZX overlap: 80% of top holdings shared

Bottom line

How much do XLV and QAAGZX overlap?

80% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 74.5% of XLV's assets and 57.7% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.

QAAGZX holds far more positions (277 vs 65), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVQAAGZX
Weight overlap (top 25)80%
Shared holdings17
Weight in shared holdings74.5%57.7%
Total positions65277
Expense ratio0.08%0.86%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings XLV and QAAGZX have in common

Holding% of XLV% of QAAGZXOverlap
Eli Lilly & Co16.51%14.06%14.06%
Johnson & Johnson10.64%6.64%6.64%
AbbVie Inc7.74%5.12%5.12%
UnitedHealth Group Inc6.57%5.88%5.88%
Merck & Co Inc5.52%4.00%4.00%
Amgen Inc3.40%1.80%1.80%
Thermo Fisher Scientific Inc3.24%2.53%2.53%
Abbott Laboratories2.75%1.91%1.91%
Gilead Sciences Inc2.73%2.79%2.73%
Intuitive Surgical Inc2.45%1.89%1.89%
CVS Health Corp2.30%0.93%0.93%
Vertex Pharmaceuticals Inc2.19%2.26%2.19%
Danaher Corp2.09%1.44%1.44%
Bristol-Myers Squibb Co2.05%2.12%2.05%
Stryker Corp1.89%1.78%1.78%
Elevance Health Inc1.46%1.54%1.46%
Cardinal Health Inc0.97%1.04%0.97%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Pfizer Inc — 2.39%
  2. Medtronic PLC — 1.75%
  3. McKesson Corp — 1.58%
  4. Cigna Group/The — 1.27%
  5. Boston Scientific Corp — 1.10%
  6. Regeneron Pharmaceuticals Inc — 1.08%
  7. HCA Healthcare Inc — 1.05%
  8. Cencora Inc — 0.96%

Only in QAAGZX

  1. Natera Inc — 1.44%
  2. Guardant Health Inc — 1.22%
  3. Royalty Pharma Plc- Cl A — 0.97%
  4. Tenet Healthcare Corp — 0.94%
  5. Kymera Therapeutics Inc — 0.89%
  6. T. Rowe Price Government Reserve Fund — 0.87%
  7. Protagonist Therapeutics Inc — 0.85%
  8. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeXLVQAAGZX
Stocks99.7%96.9%
Preferred stock—2.2%
Cash & short-term funds0.3%0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryXLVQAAGZX
US97.9%92.3%
IE2.1%0.8%
GB—1.8%
NL—1.0%
BM—0.7%
DK—0.7%
CA—0.6%
CH—0.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do XLV and QAAGZX overlap?
About 80% by weight. 17 securities appear in both funds' top 25 holdings; they make up 74.5% of XLV's assets and 57.7% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do XLV and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, AbbVie Inc, Merck & Co Inc.
Should I own both XLV and QAAGZX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, XLV or QAAGZX?
QAAGZX is broader, with 277 positions versus 65 for XLV. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.